Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: Clinical and molecular correlates
出版年份 2012 全文链接
标题
Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: Clinical and molecular correlates
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 132, Issue 7, Pages 1711-1717
出版商
Wiley
发表日期
2012-08-28
DOI
10.1002/ijc.27800
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Perivascular Epithelioid Cell Tumors (PEComas) Harboring TFE3 Gene Rearrangements Lack the TSC2 Alterations Characteristic of Conventional PEComas
- (2012) Izabela Malinowska et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
- (2011) D. M. Davies et al. CLINICAL CANCER RESEARCH
- Validation of a TFE3 Break-apart FISH Assay for Xp11.2 Translocation Renal Cell Carcinomas
- (2011) Juan-Miguel Mosquera et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
- (2011) Francis X. McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiomyolipoma Have Common Mutations in TSC2 but No Other Common Genetic Events
- (2011) Wei Qin et al. PLoS One
- Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
- (2011) Sandra L. Dabora et al. PLoS One
- A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions
- (2010) Pedram Argani et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Updating progress in sarcoma therapy with mTOR inhibitors
- (2010) J.- Y. Blay ANNALS OF ONCOLOGY
- Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa
- (2010) A. Italiano et al. ANNALS OF ONCOLOGY
- Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
- (2010) R. Quek et al. CLINICAL CANCER RESEARCH
- Resistance to Mammalian Target of Rapamycin Inhibitor Therapy in Perivascular Epithelioid Cell Tumors
- (2010) Vivek Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors
- (2010) Andrew J. Wagner et al. JOURNAL OF CLINICAL ONCOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Perivascular epithelioid cell neoplasms: pathology and pathogenesis
- (2009) Andrew L. Folpe et al. HUMAN PATHOLOGY
- Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis
- (2009) Kristen Pollizzi et al. Molecular Cancer
- The Pharmacology of mTOR Inhibition
- (2009) D. A. Guertin et al. Science Signaling
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More